{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T22:41:31Z","timestamp":1789771291304,"version":"4.0.1"},"reference-count":8,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,10,19]]},"DOI":"10.7759\/cureus.30489","type":"journal-article","created":{"date-parts":[[2022,10,19]],"date-time":"2022-10-19T19:25:35Z","timestamp":1666207535000},"source":"Crossref","is-referenced-by-count":4,"title":["Diagnosis and Management of a Patient With 5-Fluorouracil-Induced ST Elevation and Nonsustained Ventricular Tachycardia as a Late Presentation of Cardiotoxicity and Successful 5-Fluorouracil Rechallenge"],"prefix":"10.7759","author":[{"given":"Lalitha C","family":"Medepalli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tariq    S","family":"Mahmood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henry","family":"Liberman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anita M","family":"Medepalli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas  W","family":"Bagwell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-4419-6306-2_20","article-title":"Effects of 5-FU","volume":"678","author":"Wigmore PM","year":"2010","unstructured":"Wigmore PM, Mustafa S, El-Beltagy M, Lyons L, Umka J, Bennett G. Effects of 5-FU. Adv Exp Med Biol. 2010, 678:157-64. 10.1007\/978-1-4419-6306-2_20","journal-title":"Adv Exp Med Biol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0115686","article-title":"Effects of 5-fluorouracil on morphology, cell cycle, proliferation, apoptosis, autophagy and ROS production in endothelial cells and cardiomyocytes","volume":"10","author":"Focaccetti C","year":"2015","unstructured":"Focaccetti C, Bruno A, Magnani E, et al.. Effects of 5-fluorouracil on morphology, cell cycle, proliferation, apoptosis, autophagy and ROS production in endothelial cells and cardiomyocytes. PLoS One. 2015, 10:e0115686. 10.1371\/journal.pone.0115686","journal-title":"PLoS One"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1186\/s40959-019-0048-3","article-title":"5-FU induced cardiotoxicity: case series and review of the literature","volume":"5","author":"Yuan C","year":"2019","unstructured":"Yuan C, Parekh H, Allegra C, George TJ, Starr JS. 5-FU induced cardiotoxicity: case series and review of the literature. Cardiooncology. 2019, 5:13. 10.1186\/s40959-019-0048-3","journal-title":"Cardiooncology"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1177\/1758835918780140","article-title":"5-fluorouracil and cardiotoxicity: a review","volume":"10","author":"Sara JD","year":"2018","unstructured":"Sara JD, Kaur J, Khodadadi R, et al.. 5-fluorouracil and cardiotoxicity: a review. Ther Adv Med Oncol. 2018, 10:10.1177\/1758835918780140","journal-title":"Ther Adv Med Oncol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaccao.2020.06.012","article-title":"How to diagnose and manage patients with fluoropyrimidine-induced chest pain: a single center approach","volume":"2","author":"Padegimas A","year":"2020","unstructured":"Padegimas A, Carver JR. How to diagnose and manage patients with fluoropyrimidine-induced chest pain: a single center approach. JACC CardioOncol. 2020, 2:650-4. 10.1016\/j.jaccao.2020.06.012","journal-title":"JACC CardioOncol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdu055","article-title":"Effort myocardial ischemia during chemotherapy with 5-fluorouracil: an underestimated risk","volume":"25","author":"Lestuzzi C","year":"2014","unstructured":"Lestuzzi C, Vaccher E, Talamini R, et al.. Effort myocardial ischemia during chemotherapy with 5-fluorouracil: an underestimated risk. Ann Oncol. 2014, 25:1059-64. 10.1093\/annonc\/mdu055","journal-title":"Ann Oncol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.clcc.2018.09.006","article-title":"Bolus 5-fluorouracil (5-FU) in combination with oxaliplatin is safe and well tolerated in patients who experienced coronary vasospasm with infusional 5-FU or capecitabine","volume":"18","author":"Chakrabarti S","year":"2019","unstructured":"Chakrabarti S, Sara J, Lobo R, et al.. Bolus 5-fluorouracil (5-FU) in combination with oxaliplatin is safe and well tolerated in patients who experienced coronary vasospasm with infusional 5-FU or capecitabine. Clin Colorectal Cancer. 2019, 18:52-7. 10.1016\/j.clcc.2018.09.006","journal-title":"Clin Colorectal Cancer"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.21037\/jgo.2017.09.07","article-title":"Fluoropyrimidine-induced cardiac toxicity: challenging the current paradigm","volume":"8","author":"Clasen SC","year":"2017","unstructured":"Clasen SC, Ky B, O'Quinn R, Giantonio B, Teitelbaum U, Carver JR. Fluoropyrimidine-induced cardiac toxicity: challenging the current paradigm. J Gastrointest Oncol. 2017, 8:970-9. 10.21037\/jgo.2017.09.07","journal-title":"J Gastrointest Oncol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/118964-diagnosis-and-management-of-a-patient-with-5-fluorouracil-induced-st-elevation-and-nonsustained-ventricular-tachycardia-as-a-late-presentation-of-cardiotoxicity-and-successful-5-fluorouracil-rechallenge","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T14:51:52Z","timestamp":1707490312000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/118964-diagnosis-and-management-of-a-patient-with-5-fluorouracil-induced-st-elevation-and-nonsustained-ventricular-tachycardia-as-a-late-presentation-of-cardiotoxicity-and-successful-5-fluorouracil-rechallenge"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,19]]},"references-count":8,"URL":"https:\/\/doi.org\/10.7759\/cureus.30489","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-1961432\/v1","asserted-by":"object"}]},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2022,10,19]]}}}